
Our Injectables business supplies hospitals across our markets with generic injectables, supported by our manufacturing facilities in the US, Europe and MENA. In the US, we have broadened our product offering to include compounded sterile injectables.
41% of Group revenue (2020: 42%)

Our Generics business supplies oral and other
non‑injectable generic and specialty branded products in the US retail market, leveraging our
state-of-art manufacturing facility in Columbus, Ohio.
non‑injectable generic and specialty branded products in the US retail market, leveraging our
state-of-art manufacturing facility in Columbus, Ohio.
32% of Group revenue (2020: 32%)

Our Branded business supplies branded generics and in-licensed patented products from our local manufacturing facilities to retail and hospital customers across the MENA region.
26% of Group revenue (2020: 26%)